Maastricht University Medical Center (MUMC+)

Maastricht 6229 HX

2 studies enrolling now · 3 studies all time

What they study most

Anticoagulants, Hematologic Neoplasms, Platelet Aggregation Inhibitors, Symptomatic Hypertrophic Cardiomyopathy (HCM), Thrombocytopenia, Transthyretin Amyloid Cardiomyopathy (ATTR CM)

Studies at this site

• CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis — Recruiting now
• Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM — Enrolling by invitation
• Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia — Status unconfirmed